182 related articles for article (PubMed ID: 29102970)
21. Giant pubertal prolactinoma: Complete resolution following short term carbegoline treatment.
Oguz A; Tuzun D; Sahin M; Gul K
Niger J Clin Pract; 2016; 19(5):685-7. PubMed ID: 27538562
[TBL] [Abstract][Full Text] [Related]
22. Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients.
Ono M; Miki N; Kawamata T; Makino R; Amano K; Seki T; Kubo O; Hori T; Takano K
J Clin Endocrinol Metab; 2008 Dec; 93(12):4721-7. PubMed ID: 18812485
[TBL] [Abstract][Full Text] [Related]
23. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma.
Dhanwal DK; Sharma AK
Pituitary; 2011 Dec; 14(4):384-7. PubMed ID: 19381817
[TBL] [Abstract][Full Text] [Related]
24. Pons herniation into skull base after cabergoline therapy of giant prolactinoma.
Moles Herbera J; Rivero Celada D; Montejo Gañan I; Fustero de Miguel D; Fuentes Uliaque C; Vela Marín AC
Pituitary; 2015 Feb; 18(1):68-71. PubMed ID: 24522845
[TBL] [Abstract][Full Text] [Related]
25. Secondary Resistance to dopamine agonist after thirteen months of successful treatment in a 42 years old man.
Laboy-Ortiz IE; Velez-Maymí S; Hernán Martínez J; Trinidad R; Mangual M; Sanchez A; Gutierrez M; Mansilla P; Rivera C; Palermo C; de Lourdes Miranda M; Brau R
Bol Asoc Med P R; 2016; 108(1):31-36. PubMed ID: 29193928
[TBL] [Abstract][Full Text] [Related]
26. Mixed Pituitary Gangliocytoma and Prolactinoma Resistant to the Cabergoline Treatment.
Yano S; Hide T; Uekawa K; Honda Y; Mikami Y; Kuratsu JI
World Neurosurg; 2016 Nov; 95():620.e17-620.e22. PubMed ID: 27535625
[TBL] [Abstract][Full Text] [Related]
27. Evaluaton of therapy with cabergoline in men with macroprolactinoa.
Andrysiak-Mamos E; Kaźmierczyk-Puchalska A; Zochowska E; Sowińska-Przepiera E; Sagan L; Kojder I; Syrenicz A
Pomeranian J Life Sci; 2015; 61(3):263-9. PubMed ID: 27344867
[TBL] [Abstract][Full Text] [Related]
28. Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists.
De Sousa SM; Chapman IM; Falhammar H; Torpy DJ
Endocrine; 2017 Feb; 55(2):618-624. PubMed ID: 27601019
[TBL] [Abstract][Full Text] [Related]
29. Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas.
Iyer P; Molitch ME
Endocr Pract; 2011; 17(3):e55-8. PubMed ID: 21324816
[TBL] [Abstract][Full Text] [Related]
30. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
[TBL] [Abstract][Full Text] [Related]
31. [Prolactinoma treatment status in the cabergoline era].
Watanabe S; Takano S; Akutsu H; Sato H; Matsumura A
No Shinkei Geka; 2011 Nov; 39(11):1045-54. PubMed ID: 22036815
[TBL] [Abstract][Full Text] [Related]
32. Prolactinomas, dopamine agonists and headache: two case reports.
Levy MJ; Matharu MS; Goadsby PJ
Eur J Neurol; 2003 Mar; 10(2):169-73. PubMed ID: 12603293
[TBL] [Abstract][Full Text] [Related]
33. Reduction in the size of prolactin-producing pituitary tumor after Cabergoline administration.
Melis GB; Gambacciani M; Paoletti AM; Mais V; Sghedoni D; Fioretti P
Fertil Steril; 1989 Sep; 52(3):412-5. PubMed ID: 2570719
[TBL] [Abstract][Full Text] [Related]
34. Hyperprolactinemia: pathophysiology and management.
Verhelst J; Abs R
Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
[TBL] [Abstract][Full Text] [Related]
35. [Cabergoline-induced tension pneumocephalus in a patient with giant invasive prolactinoma. Case report].
Castro-Castro J; Torre-Eiriz JA; Pinzón-Millán A; Pastor-Zapata A
Neurocirugia (Astur); 2011 Dec; 22(6):558-61; discussion 561. PubMed ID: 22167286
[TBL] [Abstract][Full Text] [Related]
36. Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy.
Delgrange E; Donckier J
J Clin Endocrinol Metab; 1997 Aug; 82(8):2755-6. PubMed ID: 9253367
[No Abstract] [Full Text] [Related]
37. Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report.
Kawabata Y; Ueno Y; Horikawa F; Miyake H; Miki N; Ono M
Surg Neurol; 2008 Jan; 69(1):85-8; discussion 88. PubMed ID: 17967478
[TBL] [Abstract][Full Text] [Related]
38. CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas.
Leong KS; Foy PM; Swift AC; Atkin SL; Hadden DR; MacFarlane IA
Clin Endocrinol (Oxf); 2000 Jan; 52(1):43-9. PubMed ID: 10651752
[TBL] [Abstract][Full Text] [Related]
39. Clinical practice. Prolactinomas.
Klibanski A
N Engl J Med; 2010 Apr; 362(13):1219-26. PubMed ID: 20357284
[No Abstract] [Full Text] [Related]
40. Update on prolactinomas. Part 2: Treatment and management strategies.
Wong A; Eloy JA; Couldwell WT; Liu JK
J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
